GlassScriptPhysician profile
Ann M Ressetar
NPI 1225026719
$579.87
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $26.58 · 2021: $206 · 2022: $17.38 · 2023: $72.39 · 2024: $26.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $275.01 | 2019-2024 | |
| Avanos Medical | $72.39 | 2023 | On-Q* Pump and Accessories |
| Aspira Women'S Health INC | $50.36 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $28.39 | 2019 | |
| Becton, Dickinson and Company | $24.22 | 2021 | |
| Abbott Laboratories | $23.98 | 2021 | |
| Therapeuticsmd, INC. | $23.59 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $19.19 | 2021 | |
| Amgen INC. | $17.89 | 2021 | |
| Agile Therapeutics, INC. | $16.68 | 2021 | |
| Evofem Biosciences, INC. | $14.87 | 2021 | |
| Dysis Medical, INC. | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Ressetar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.